Title: Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study
Authors: Osborne, C Kent ×
Neven, Patrick
Dirix, Luc Y
Mackey, John R
Robert, Jean
Underhill, Craig
Schiff, Rachel
Gutierrez, Carolina
Migliaccio, Ilenia
Anagnostou, Valsamo K
Rimm, David L
Magill, Patrick
Sellers, Mark #
Issue Date: Mar-2011
Publisher: Association for Cancer Research
Series Title: Clinical Cancer Research vol:17 issue:5 pages:1147-1159
Abstract: Increased growth factor signaling may contribute to tamoxifen resistance. This randomized phase II trial assessed tamoxifen plus placebo or the epidermal growth factor receptor inhibitor gefitinib in estrogen receptor (ER)-positive metastatic breast cancer.
ISSN: 1078-0432
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science